PharmaInformatic´s Knowledge Bases on ADME and Toxicology

    PharmaInformatic develops and licenses ADME/Tox knowledge bases for pharmaceutical research to optimize and accelerate drug discovery and development. We have currently launched PACT-F, the largest knowledge base on bioavailability worldwide.

    PACT-F contains experimental bioavailability results of clinical trials in humans and preclinical trials in animals. The results and conditions of those trials have been taken manually from more than 5000 scientific research articles related to bioavailability.
     

        

The development of PACT-F commenced in 2005. PACT-F is now the largest knowledge base on bioavailability worldwide. It contains 8296 records, which describe in detail the results of clinical trials in humans and preclinical trials in animals.

 

 


LEAD
OPTIMIZATION
with
IMPACT-F:

==> selects oral bioavailable
drugs

==> increases efficacy of clinical trials

==> results
directly available

Only compound structure needed
==> no further assays, synthesis
 or costs
 

© Copyright 2004-2017 PharmaInformatic Boomgaarden. All rights reserved.         Site map           Contact         Terms of Use         Imprint        

 








Recent News:

Cooperation with
BRIDGE
BIORESEARCH
signed.


Bioavailability prediction of drug candidates for
treatment of Type 2 diabetes
(more)

...and in short time our development project was taken to the next step."
 



PharmaInformatic and
UNIZYME
Laboratories
sign
cooperation agreement:


Selection and prioritisation
 of lead compounds
for treatment of
inflammatory diseases
based on estimated oral bioavailability in humans with IMPACT-F.
(more)